We are pleased to announce our upcoming participation at Drug, Chemicals, and Associated Technologies (DCAT) conference in New York City from March 20-22, 2018.
DCAT conference 2018
At DCAT, Phyton Biotech will be meeting with global leaders in the pharmaceutical manufacturing industry which use Phyton’s key products, Paclitaxel and Docetaxel Active Ingredients.
Phyton Biotech is also planning to meet with companies that are involved in the development of novel oncology formulations using Paclitaxel or Docetaxel active pharmaceutical ingredients, and traditional Chinese medicines (TCM), as well as food or cosmetics that use unique plant molecules which may be derived from plant cell fermentation technology (PCF®).
Global leaders in plant cell fermentation
As a biotechnology leader, Phyton has a successful track record of developing and implementing innovative contract solutions based on plant cell culture development for clients around the world using our revolutionary and proprietary Plant Cell Fermentation (PCF®) platform.
We offer comprehensive services for the development and commercialization of plant-based molecules, extracts and recombinant products, serving the pharmaceutical, Chinese traditional medicine, cosmetic, agricultural and food ingredient industries.
Connect with us at DCAT
If you would like to meet at DCAT, or are interested to know more, please contact Jackie.Labbe@phytonbiotech.com.
Conference: DCAT Week
Hosted by: Drug Chemical and Associated Technologies (DCAT) Association
March 19 – 22, 2018
New York City, USA